Circulatory Health and COVID-19

The link between circulatory diseases and COVID-19 has become increasingly evident with the growing number of patients who have been diagnosed and treated worldwide.

The Global Coalition for Circulatory Health (GCCH) brings together 32 international, regional and national stakeholders in circulatory health to drive the urgent action needed to combat heart disease and stroke. Each member has been working actively within its own speciality and constituency to provide relevant and timely information related to the crisis.

By working together, the GCCH has a huge opportunity to provide a comprehensive and global perspective on the circulatory risk factors, such as hypertension, diabetes, obesity, and tobacco use, and outcomes, including renal failure, vascular problems, and cardiovascular disease, associated with COVID-19.

We are therefore delighted to invite you to join our upcoming webinar series:

Please register below to join the Webinars

16 June – Circulatory Risk Factors for COVID-19 (watch video)
Speakers:
Prof Vivekanand Jha, International Society of Nephrology
Prof Andrew Boulton, International Diabetes Federation
Prof Claudio Borghi, Italian Society of Hypertension
Prof Donna H. Ryan, World Obesity Federation
Dr Eduardo Bianco, FCA Regional Coordinator for the Americas
Moderated by WHF Past President Prof David Wood.

30 June – COVID-19 and Circulatory Conditions: Mitigating Poor Outcomes (register)
Speakers:
Prof Marc Fisher, World Stroke Organization
Dr Anuradha Lala-Trindade, World Heart Federation
Dr Peter Libby, International Atherosclerosis Society
Prof Gianfranco Parati, World Hypertension League
Moderated by WHF Past President Prof David Wood.

14 July – Supporting the Healthcare Workforce: COVID-19 and Public Health in the Circulatory Space (register)

We look forward to welcoming you to this series of cross-sectoral conversations, presented by the Global Coalition for Circulatory Health.